Week 416 Review - This week comes 2nd only to last week's best ever week

I posted on Tuesday because I wanted to celebrate the astronomical surge in OPTI:Optibiotix, and although it briefly touched 42p the next morning, the heady heights didn't last and we ended the week on 27.5p. That still gave the 2nd best week ever, with the deficit between cost and value reducing by £18,716 to £83,228 and total portfolio value going above £100k to £103,103.

There was only one share that dropped more than 6%, and that didn't really as I bought BARC:Barclays in my trading account, so the commission and spread contributed to it ending down by 6%.

ANTO:Antofagasta had another good week, climbing 7% to go 11% up. Just 2 weeks until my final purchase so ideally it won't climb too much more just yet.

SBTX:SkinBioTherapeutics went up 2.25p which is a good 9%. Not sure if it was on the back of the OPTI:Optibiotix rise, but nothing else happened that might trigger it.

Similarly, PBX:Probiotix Health climbed 2p which is 9% of my dividend holding IPO price, but 26% up on my later purchases.

OPTI:Optibiotix wins Share of the Week for a 2nd week, climbing 6.9p which is 71% of my cheapest holding price, or 7% of my most expensive holding price. Potential profits are now £6,230 for my cheaper shares, but still 70% down on my most expensive.

Here's the ISA and shares portfolio after week 52 of year 8.

			Weekly Change
Cash	£242.44		-£5.62
Portfolio cost	£87,854.54		+£0
Portfolio sell value (bid price-commission)	£45,717.91	(-58.0%)	+£8,634.88
Potential profits	£2,647.90		+£1,399.42
Yr 8 Dividends	£142.51		+£0
Yr 8 Interest	£1.93		+£0.14
Yr 8 Profit from sales	-£10,795.53		+£0
Yr 8 proj avg monthly profit	-£891.90	(-18.0%)	+£17.01
Total Dividends	£11,911.43		+£0
Total Interest	£1.93		+£0.14
Total Profit from sales	£17,298.53		+£0
Average monthly cash profit	£300.35	(6.0%)	-£0.78
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	48%		+0%

The last week of year 8. Profit this year was a disaster thanks to DDDD:4D Pharma going bust, so the average monthly loss was £891 (18%), making this by far my worst year. It hammered my long term performance too, although that's benefited from the PBX:Probiotix share dividend. Averaging £300 a month over 8 years isn't bad, or at least wouldn't be if the portfolio was breaking even. It's a long way below my 10% target though.

Increase in potential profits is mostly OPTI:Optibiotix, although £214 the profit is GAW:Games Workshop.

On Tuesday we touched the injection line, but now we're a fair way below it.

We're higher than the highest point on the trend line, so I would hope it starts to flatten quite quickly.

The SIPP looks like this after week 400 overall and week 36 of year 8.

			Weekly Change
Cash	£151.03		+£80.33
Portfolio cost	£96,015.54		+£0
Portfolio sell value (bid price - commission)	£55,535.17	(-42.2%)	+£10,135.23
Potential profits	£4,096.36		+£1,817.16
Yr 8 Dividends	£239.37		+£18.44
Yr 8 Interest	£3.82		+£0.33
Yr 8 Profit from sales	-£9,597.85		+£0
Yr 8 proj avg monthly profit	-£1,136.71	(-20.9%)	+£34.69
Total Dividends	£14,382.15		+£18.44
Total Interest	£4.07		+£0.33
Total Profit from sales	£10,835.90		+£0
Average monthly cash profit	£261.48	(4.8%)	-£0.46
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	37%		+0%

Cash went up thanks to a tax rebate and £18 dividend from III:3i Group. Huge £10k rise in portfolio value and potential profits up mainly due to OPTI:Optibiotix, but also ANTO:Antofagasta now in profit by £78 and III:3i Group in profit by £219.

This one is a lot closer to the injection line, A whole year of decline has been reversed in 2 weeks.

As with the ISA, if the price doesn't drop back, then the trend line should flatten quickly.

The trading account looks like this after week 366 overall and week 2 of year 8.

			Weekly Change
Cash	£273.24		+£252.98
Portfolio cost	£1,794.51		+£31.01
Portfolio sell value (bid price - commission)	£1,183.44	(-34.1%)	-£53.41
Potential profits	£0		-£13.38
Year 8 Dividends	£0		+£0
Year 8 Interest	£0		+£0
Year 8 Profit	£283.99		+£283.99
Yr 8 proj avg monthly profit	£615.30	(+411.5%)	+£615.30
Dividends	£60.10		+£0
Interest	£0.03		+£0
Profit from sales	-£646.70		+£283.99
Average monthly cash profit	-£6.94	(-4.6%)	+£3.40
(Sold stocks profit + Dividends - Fees / Months)

I sold my 2,469 shares in OPTI:Optibiotix at 31.56p and made £283.98 (57.3%) profit. At the time I regretted not waiting, as it was 37p later in the day, but ended the week 4p down on what I sold at, so mustn't grumble. It means there's half the cash I need to buy another share and get back to 5 in this portfolio, and it reduces the long-term losses by £3 a month to £6.

I bought 317 shares in BARC:Barclays as their share price had plummeted despite reasonable results. I was hoping they would bounce back on the day I bought them, but they didn't, in fact they dropped further from where I bought them. If I hold them for a few weeks I'll get a small interim dividend of about £3, but I hope I don't keep them that long as I'm rather eager for the trading account to work like it's meant to.

Getting closer to cost price, but still £1k down on injection amount, so this account is still a disaster.

Good news that we stay above the trend line despite cashing in some profit.

It's difficult to know if the surge in OPTI:Optibiotix share price will continue or stall. If we can keep some momentum of news flow then maybe there's a chance of sustaining the recovery. Otherwise boredom may set in and we go back to our 2-year long drift.

Optibiotix has gone completely mad!

I had to write a mid-week blog post as it might all go south tomorrow and I wanted to register the two best ever days in my portfolio.

There must be institutions buying OPTI:Optibiotix, because the trading amounts are colossal. 8.5 million shares today, and it's been similar every day since last Wednesday.

Today they went up 10.5p from 27p to 37.5p

I've made up £43,798 of losses in 2 days this week, and £32,195 last week. That's £75k in 5 trading days.

The trigger was the RNS last Wednesday which was the first time major global corporate partners were mentioned in connection with Sweetbiotix, these being Kelloggs, Nestle, Coca Cola , Firmenich, Tereos, Cargill, Arla ,Tate and Lyle, Agropur, Givaudan and Tata.

Add to that scares on the health damage of sucralose and aspartame, and it seems to have created a perfect storm.

Volumes have been massive, so surely this must be institutional investors? Given it requires less than 3 million shares to need to declare a holding, will we see any announcements this week?

My OPTI:Optibiotix holding is 241,175 shares costing £116,655, so my average purchase price is around 48p.

I only need the same price rise as happened today to happen again before the end of the week, and my OPTI holding will be in profit.

As it is, I have the purchases split into price bands that I paid for them, so although I'm still £26k down altogether, I have some holdings in profit which are £12,218 up at the moment.

I did sell my trading pot at 31.56p which turns out to be way too early, but it made £283 (57%) profit which is more than my trading account usually makes. Haven't a clue what to buy with it next.

I'm writing this today because I'm very, very happy. I may not be so happy by Friday if there's a re-trace, so I want to write nice words, as there have been 2 years of solid misery, and this is the moment I've been hoping for, for a very long time.

The effect on my portfolio has been to increase the value to £128,110 and reduce the deficit between cost and value to £58,146. 

I'm going to celebrate with a bottle of wine this evening, and I have a day off tomorrow so I can get well away from a computer screen in case it all goes downhill...

Week 415 Review - Best week ever as Optibiotix goes berserk!

What a week! An RNS from OPTI:Optibiotix finally listed the major global corporates we're working with on Sweetbiotix, and the share price rocketed. The result was a reduction in the deficit between cost and value of a record £32,195 to £101,944 and an increase in portfolio value to £84,027.

It was a great week all round, with no big losers at all.

IGG:IG Group posted a good trading update and went up 5%, although I was hoping for a bit more. They are still 19% down but I've had £101 dividends from them and will continue to hold in anticipation of a future re-rate.

PSN:Persimmon went up 7% for the second week in a row, buoyed by lower than expected inflation and the hope mortgage rates will stop rising.

PBX:Probiotix Health went up for the first time since the lock-in period ended. It was only 1p but that was 5% in my main holding and 12% for my recent purchases.

Share of the Week by absolutely miles was OPTI:Optibiotix which went from 7.8p bid price last week to 20.6p this week, a rise of 12.8p. That's more than double! The percentage increase varied between my highest price holding bought for 90p which climbed 14%, to my recent purchases averaging 9.55p which went up 133%.

Here's the ISA and shares portfolio after week 51 of year 8.

			Weekly Change
Cash	£248.06		+£10.73
Portfolio cost	£87,854.54		+£499.97
Portfolio sell value (bid price-commission)	£37,083.03	(-57.8%)	+£14,610.60
Potential profits	£1,248.48		+£1,095.26
Yr 8 Dividends	£142.51		+£10.70
Yr 8 Interest	£1.79		+£0
Yr 8 Profit from sales	-£10,795.53		+£0
Yr 8 proj avg monthly profit	-£908.91	(-18.3%)	+£19.10
Total Dividends	£11,911.43		+£10.70
Total Interest	£1.79		+£0
Total Profit from sales	£17,298.53		+£0
Average monthly cash profit	£301.13	(6.1%)	-£0.62
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	48%		-1%

I got a £10 dividend from PLUS:Plus500 and also added £500 which I intended to use to buy PBX:Probiotix Health, but AJ Bell wouldn't let me buy them despite it being ok a few weeks ago. It sounds like lots of people have had trouble buying the shares, so the Aquis exchange is clearly not fit for purpose and these need to be listed on AIM.

Instead I bought another 6,471 shares in JLP:Jubilee Metals at 7.5725p costing £499.97. They promptly dropped to 7.4p. I'm surprised, as they gave a pretty good trading statement this week.

Portfolio value rocketed by £14,610 mainly thanks to OPTI:Optibiotix, but it's still 57% down so there's a long way to go. However, now I've split my OPTI:Optibiotix holding into shares bought at 10p intervals, the holding bought for an average of 15p went £1,065 into profit, and with an increase in GAW:Games Workshop, potential profits rose £1,095.

Almost halved the distance back to the injection line, and no need to lower the Y axis any more.

That's more like it - much higher than the trend line - lets hope we can drag it back up.

The SIPP looks like this after week 399 overall and week 35 of year 8.

			Weekly Change
Cash	£70.70		+£0
Portfolio cost	£96,015.54		+£0
Portfolio sell value (bid price - commission)	£45,399.94	(-52.7%)	+£17,291.36
Potential profits	£2,279.20		+£2,067.76
Yr 8 Dividends	£220.93		+£0
Yr 8 Interest	£3.49		+£0
Yr 8 Profit from sales	-£9,597.85		+£0
Yr 8 proj avg monthly profit	-£1,171.40	(-21.6%)	+£34.45
Total Dividends	£14,363.71		+£0
Total Interest	£3.74		+£0
Total Profit from sales	£10,835.90		+£0
Average monthly cash profit	£261.94	(4.8%)	-£0.66
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	37%		+0%

Fairly quiet, except for the stonking £17,291 rise in value and my 9.5p OPTI:Optibiotix holding going £1,955 into profit, my 18.2p holding going £17 into profit and my 18.88p holding going £77 into profit, all helping potential profits rise by £2,067.

I reckon that has pretty much halved the distance to the injection line

A glorious sight.

The trading account looks like this after week 365 overall and week 1 of year 8.

			Weekly Change
Cash	£20.26		+£0
Portfolio cost	£1,763.50		+£0
Portfolio sell value (bid price - commission)	£1,205.84	(-31.6%)	+£293.78
Potential profits	£13.38		+£13.38
Year 8 Dividends	£0		+£0
Year 8 Interests	£0		+£0
Year 8 Profit	£0		+£0
Yr 8 proj avg monthly profit	£0	(+0%)	+£0
Dividends	£60.10		+£0
Interest	£0.03		+£0
Profit from sales	-£930.69		+£0
Average monthly cash profit	-£10.34	(-7.0%)	+£0.02
(Sold stocks profit + Dividends - Fees / Months)

What a way to start the new year for this account. Not only do I lose the miserable negative stats suffered from the Year 7 DDDD:4D Pharma collapse, but OPTI:Optibiotix drags the value up by £293 and goes £13 into profit. Surely I won't actually get to sell a share in my trading account?!

It doesn't look as impressive when you see how far it needs to go to get back to the injection line.

Much relief as we go back above the trend line.

I guess there is a risk this week will be a blip and OPTI:Optibiotix will sink again, but I think the market finally recognises that Sweetbiotix is going to happen fairly soon. Launches may be a while off, but companies will need to buy the product long before that, so the key announcements will be around contract signing. One big global contract should see all my losses wiped out. Hope has definitely been re-kindled.

Week 414 Review - Recent gains destroyed as we hit a new all-time low

Absolute misery as OPTI:Optibiotix drops again causing the deficit between cost and value to widen by £2,703 to £134,140, which is a new all-time worst deficit. Portfolio value dropped to £50,993. If it had gone below £50k I may have just jacked the whole thing in.

OPTI:Optibiotix only dropped 1.3p, but for some of my recent purchases that was 10%, and the shares I bought only last week dropped 14%. Every time I buy some more, the price drops. It's been happening for years from 90p all the way down to below 10p.

The rest of the portfolio had quite a good week.

RIO:Rio Tinto and WHR:Warehouse REIT both recovered from recent poor spells by increasing 5%, and PAGE:Page Group rose 6% and is now only 7% down.

PSN:Persimmon went up 7% but is still 27% down.

Share of the Week is ANTO:Antofagasta which went up 10% but I don't really know why. They are back in profit and 4% up, so clearly it's time for my monthly investment. My August purchase will be the last one, then I'll have to find a new magic formula share to buy every month.

Here's the ISA and shares portfolio after week 50 of year 8.

			Weekly Change
Cash	£237.33		-£14.22
Portfolio cost	£87,354.57		+£0
Portfolio sell value (bid price-commission)	£21,972.46	(-74.8%)	-£1,357.81
Potential profits	£153.22		+£29.70
Yr 8 Dividends	£131.81		+£0
Yr 8 Interest	£1.79		+£0
Yr 8 Profit from sales	-£10,795.53		+£0
Yr 8 proj avg monthly profit	-£928.01	(-18.8%)	+£18.94
Total Dividends	£11,900.73		+£0
Total Interest	£1.79		+£0
Total Profit from sales	£17,298.53		+£0
Average monthly cash profit	£301.75	(6.1%)	-£0.73
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	49%		+0%

Cash dropped because I did a re-set. Usually I add and subtract income and expenditure, but clearly I occasionally forget because I was £14 out and had to do a correction.

Portfolio value dropped by £1,357 and is very nearly 75% down

Follow that trend line!

The SIPP looks like this after week 398 overall and week 34 of year 8.

			Weekly Change
Cash	£70.70		-£195.17
Portfolio cost	£96,015.54		+£241.14
Portfolio sell value (bid price - commission)	£28,108.58	(-70.7%)	-£1,313.99
Potential profits	£211.44		+£67.19
Yr 8 Dividends	£220.93		+£0
Yr 8 Interest	£3.49		+£0
Yr 8 Profit from sales	-£9,597.85		+£0
Yr 8 proj avg monthly profit	-£1,205.85	(-22.2%)	+£35.35
Total Dividends	£14,363.71		+£0
Total Interest	£3.74		+£0
Total Profit from sales	£10,835.90		+£0
Average monthly cash profit	£262.60	(4.8%)	-£0.76
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	37%		+0%

Portfolio cost went up as I bought my monthly 17 shares in ANTO:Antofagasta at 1402.6447p costing £241.14 with commission and stamp duty. As with the ISA the portfolio value dropped by over £1k but at least potential profits increased by 67.

Misery.

The trading account looks like this after week 364 overall and week 52 of year 7.

			Weekly Change
Cash	£20.26		+£0
Portfolio cost	£1,763.50		+£0
Portfolio sell value (bid price - commission)	£912.06	(-48.3%)	-£32.09
Potential profits	£0		+£0
Year 7 Dividends	£0.00		+£0
Year 7 Interests	£0.03		+£0
Year 7 Profit	-£1,157.99		+£0
Yr 7 proj avg monthly profit	-£96.44	(-65.6%)	+£1.89
Dividends	£60.10		+£0
Interest	£0.03		+£0
Profit from sales	-£930.69		+£0
Average monthly cash profit	-£10.36	(-7.1%)	+£0.03
(Sold stocks profit + Dividends - Fees / Months)

Last week's gains were wiped out and all is bleak and horrible

Let's get this horrible week saved and posted so we can welcome Week 415 with open arms...

Week 413 Review - Optibiotix continues to recover

A rare 2nd positive week in a row as OPTI:Optibiotix increased again, improving the deficit between cost and value by £1,962 to £131,436, and total portfolio value increased to £53,455.

Not a great week for some magic formula shares, with both IGG:IG Group and III:3i Group dropping 5% for no apparent reason.

OPTI:Optibiotix wins Share of the Week, which is a rare occurrence, with a 7% increase in one of my holdings, but that's my best one and is still down 40%. Most of my holdings are down between 75% and 90%.

Here's the ISA and shares portfolio after week 49 of year 8.

			Weekly Change
Cash	£251.55		+£11.92
Portfolio cost	£87,354.57		+£0
Portfolio sell value (bid price-commission)	£23,330.27	(-73.3%)	+£1,287.46
Potential profits	£123.52		-£14.30
Yr 8 Dividends	£131.81		+£11.64
Yr 8 Interest	£1.79		+£0.28
Yr 8 Profit from sales	-£10,795.53		+£0
Yr 8 proj avg monthly profit	-£946.95	(-19.2%)	+£20.81
Total Dividends	£11,900.73		+£11.64
Total Interest	£1.79		+£0.28
Total Profit from sales	£17,298.53		+£0
Average monthly cash profit	£302.48	(6.1%)	-£0.61
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	49%		+0%

The £11 dividend was from WHR:Warehouse REIT, and 28p interest was a thrill. Portfolio value went up by £1,287 but is still 73% down, and potential profits dropped by £14. Long term performance of 6.1% is 4% down on target, but it doesn't really mean anything when the portfolio value has dropped so much.

A slight tick up but still in danger of needing to adjust the Y axis lower. 

It's nice to have been above the trend line for some time now, but not enough to change it's direction.

The SIPP looks like this after week 397 overall and week 33 of year 8.

			Weekly Change
Cash	£265.87		-£145.27
Portfolio cost	£95,774.40		+£923.42
Portfolio sell value (bid price - commission)	£29,181.43	(-69.5%)	+£640.48
Potential profits	£144.25		-£272.55
Yr 8 Dividends	£220.93		+£0
Yr 8 Interest	£3.49		+£0.88
Yr 8 Profit from sales	-£9,597.85		+£222.31
Yr 8 proj avg monthly profit	-£1,241.20	(-22.9%)	+£69.01
Total Dividends	£14,363.71		+£0
Total Interest	£3.74		+£0.88
Total Profit from sales	£10,835.90		+£222.31
Average monthly cash profit	£263.36	(4.8%)	+£1.77
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	37%		+0%

I know I have vowed never to buy any more OPTI:Optibiotix shares, but I can't stand by while people hoover them up at these prices, so I did buy some more this week. I added £360 to my SIPP to go with some dividend cash and bought 5,407 shares at 9.14p costing £506.15.

Then I decided I couldn't be bothered waiting for NUM:Numis Corp to get taken over, as the share price has stagnated and there's only one small dividend to come. I sold my 374 shares for 332.5802p making £222.30 (21.7%) profit and liberating £1,231.90. I used that to buy 12,525 shares in OPTI:Optibiotix at 9.74p costing £1,231.89.

This caused potential profits to drop by £272 as III:3i Group dropped 5% to add to the cashing in of £222 profit. Value went up by £640.

Again a very slight tick up but a long, long way below the injection line.

This account has been bumping along the trend line rather than just above it.

The trading account looks like this after week 363 overall and week 51 of year 7.

			Weekly Change
Cash	£20.26		+£0
Portfolio cost	£1,763.50		+£0
Portfolio sell value (bid price - commission)	£944.15	(-46.5%)	+£34.57
Potential profits	£0		+£0
Year 7 Dividends	£0.00		+£0
Year 7 Interests	£0.03		+£0
Year 7 Profit	-£1,157.99		+£0
Yr 7 proj avg monthly profit	-£98.33	(-66.9%)	+£1.97
Dividends	£60.10		+£0
Interest	£0.03		+£0
Profit from sales	-£930.69		+£0
Average monthly cash profit	-£10.39	(-7.1%)	+£0.03
(Sold stocks profit + Dividends - Fees / Months)

The increase in OPTI:Optibiotix gave this a little boost, but we're still a long way from being able to sell anything.

Still looks pretty bad.

Below the trend line, which is bad.

I'm 2 weeks behind so on a bit of a catch-up, and eager to post this week and next because Week 415 has just been very interesting!

Week 412 Review - Saved from new all-time low by late Optibiotix rally

On OPTI:Optibiotix results day the price dropped and I was down £4,000 on the week and preparing for yet another blog of woe and all-time low. However, in a rare huge volume day on Friday, the OPTI share price recovered and ended up 1p higher than last week. Unfortunately PBX:Probiotix didn't recover and lost a load of money, so I only ended up £631 better off instead of the £2,000 OPTI increase, but that was still the best week in ages. The deficit reduced to £133,399 and value increased to £50,596.

JLP:Jubilee Metals had another bad week, dropping 8% in some of my holdings and reducing the gains this week.

PBX:Probiotix Health fell another 5% in my main holding and 13% in my recent holding and didn't bounce back like OPTI:Optibiotix did.

There was some good news, with some shares that were hammered last week recovering a bit. 

GAW:Games Workshop went up 5% and are now 13% in profit.

III:3i Group recovered most of last week's loss to go up 5% and are now 19% in profit.

IES:Invinity Energy have been on a bit of a run after being tipped, and climbed 5% this week but are still 79% down.

Share of the week is ASHM:Ashmore Group which climbed 6% to remove most of last week's loss, but are still 25% down.

Here's the ISA and shares portfolio after week 48 of year 8.

			Weekly Change
Cash	£239.63		+£0
Portfolio cost	£87,354.57		+£0
Portfolio sell value (bid price-commission)	£22,042.81	(-74.8%)	+£330.04
Potential profits	£137.82		-£0.70
Yr 8 Dividends	£120.17		+£0
Yr 8 Interest	£1.51		+£0
Yr 8 Profit from sales	-£10,795.53		+£0
Yr 8 proj avg monthly profit	-£967.76	(-19.6%)	+£20.59
Total Dividends	£11,889.09		+£0
Total Interest	£1.51		+£0
Total Profit from sales	£17,298.53		+£0
Average monthly cash profit	£303.09	(6.2%)	-£0.74
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	49%		+0%

Not much happened. Portfolio rise of £330 is a bit feeble given OPTI:Optibiotix went up by over £1,000.

We've been above the tend line for quite a while now, but steadfastly running in parallel.

The SIPP looks like this after week 396 overall and week 32 of year 8.

			Weekly Change
Cash	£411.14		+£0
Portfolio cost	£94,850.98		+£0
Portfolio sell value (bid price - commission)	£27,617.53	(-70.9%)	+£321.14
Potential profits	£416.80		+£49.29
Yr 8 Dividends	£220.93		+£0
Yr 8 Interest	£2.61		+£0
Yr 8 Profit from sales	-£9,820.16		+£0
Yr 8 proj avg monthly profit	-£1,310.21	(-24.3%)	+£42.27
Total Dividends	£14,363.71		+£0
Total Interest	£2.86		+£0
Total Profit from sales	£10,613.59		+£0
Average monthly cash profit	£261.59	(4.8%)	-£0.66
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	37%		+0%

Almost the same as the ISA, climbing by just £321 but at least adding £49 to potential profits.

Nothing to see here.

The trading account looks like this after week 362 overall and week 50 of year 7.

			Weekly Change
Cash	£20.26		+£0
Portfolio cost	£1,763.50		+£0
Portfolio sell value (bid price - commission)	£909.58	(-48.4%)	-£19.81
Potential profits	£0		+£0
Year 7 Dividends	£0.00		+£0
Year 7 Interests	£0.03		+£0
Year 7 Profit	-£1,157.99		+£0
Yr 7 proj avg monthly profit	-£100.30	(-68.2%)	+£2.05
Dividends	£60.10		+£0
Interest	£0.03		+£0
Profit from sales	-£930.69		+£0
Average monthly cash profit	-£10.42	(-7.1%)	+£0.03
(Sold stocks profit + Dividends - Fees / Months)

The rise in OPTI:Optibiotix wasn't enough to counteract the drop in JLP:Jubilee Metals, so this account drops yet again by £19.

Grim

I'm hoping the recovery in OPTI:Optibiotix after results means that people who have sold out are starting to buy back in. Getting up from these desperately low prices is my only hope of being able to report a less dreadful performance. I think I need to face the fact that the share price isn't going to go anywhere until a big Sweetbiotix deal is announced. My worry is, if Sweetbiotix is so great and global corporates are working with us, why are none of them investing in the company or trying to buy us out? I'd be worried about relying on a penny share company with virtually no assets to provide a key ingredient of my global brand. I'm starting to think my early retirement plans are not going to happen, in fact I may not get to retire at all.

Week 411 Review - Big drop in Jubilee Metals brings new all-time low.

I knew the tiny rise last week would get obliterated, as JLP:Jubilee Metals plummeted and there were big drops all over the place, so the deficit between cost and value widened by £1,780 to a record high of £134,030 and portfolio value dropped to £50,609.

Worst performer was PSN:Persimmon which dropped 10%. I suspect house builders will get hammered now mortgage rates are going up, but this is a long term investment for the dividend so I can wait for it to turn around.

JLP:Jubilee Metals fell 10% in some of my holdings and was the main contributor to this week's losses.

ASHM:Ashmore Group dive-bombed 9% to go 31% down. Yet another disaster for my magic formula.

III:3i Group is one of my top performers, but still dropped 8%, Thankfully they remained 14% in profit.

EDV:Endeavour Mining went from profit to loss, dropping 7% to go 6% down.

WHR:Warehouse REIT also dropped 7% and is now 30% down.

RIO:Rio Tinto dropped another 6% to go 17% down. I think I was naive thinking I could manage a virtual stop loss at 15% in these markets. Shares are so volatile I would have sold every single investment. I need to face the fact that it's better to hang on in there as long as the company fundamentals remain strong.

ANTO:Antofagasta waited until I'd bought some with my monthly investment, then promptly dropped 6% and is now 4% down and well below what I just paid.

CAML:Central Asia Metals looked like they were recovering, but dropped 5% so my original holding is now 35% down.

Nothing climbed by 5% or more so nothing deserves Share of the Week.

Here's the ISA and shares portfolio after week 47 of year 8.

			Weekly Change
Cash	£239.63		+£23.34
Portfolio cost	£87,354.57		+£0
Portfolio sell value (bid price-commission)	£21,712.77	(-75.1%)	-£767.41
Potential profits	£138.52		-£116.93
Yr 8 Dividends	£120.17		+£23.34
Yr 8 Interest	£1.51		+£0
Yr 8 Profit from sales	-£10,795.53		+£0
Yr 8 proj avg monthly profit	-£988.35	(-20.1%)	+£23.68
Total Dividends	£11,889.09		+£23.34
Total Interest	£1.51		+£0
Total Profit from sales	£17,298.53		+£0
Average monthly cash profit	£303.83	(6.2%)	-£0.49
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	49%		+0%

I got a £23 dividend from PAGE:Page Group, which was the only good news as value dropped £767 and potential profits dropped £116.

Looks like I am going to have to drop the Y axis soon.

Absolutely remarkable how this is following the trend line downwards so closely

The SIPP looks like this after week 395 overall and week 31 of year 8.

			Weekly Change
Cash	£411.14		+£102.49
Portfolio cost	£94,850.98		+£0
Portfolio sell value (bid price - commission)	£27,296.39	(-71.2%)	-£961.54
Potential profits	£367.51		-£139.84
Yr 8 Dividends	£220.93		+£39.99
Yr 8 Interest	£2.61		+£0
Yr 8 Profit from sales	-£9,820.16		+£0
Yr 8 proj avg monthly profit	-£1,352.48	(-25.0%)	+£50.86
Total Dividends	£14,363.71		+£39.99
Total Interest	£2.86		+£0
Total Profit from sales	£10,613.59		+£0
Average monthly cash profit	£262.25	(4.9%)	-£0.22
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	37%		+0%

Cash went up £102 thanks to a tax rebate and dividends from NUM:Numis Corp (£22) and CEY:Centamin (£17). Big drop of £961 in portfolio value and £139 potential profits were lost.

I just don't have the words

The trading account looks like this after week 361 overall and week 49 of year 7.

			Weekly Change
Cash	£20.26		+£0
Portfolio cost	£1,763.50		+£0
Portfolio sell value (bid price - commission)	£929.39	(-47.3%)	-£51.92
Potential profits	£0		+£0
Year 7 Dividends	£0.00		+£0
Year 7 Interests	£0.03		+£0
Year 7 Profit	-£1,157.99		+£0
Yr 7 proj avg monthly profit	-£102.35	(-69.6%)	+£2.13
Dividends	£60.10		+£0
Interest	£0.03		+£0
Profit from sales	-£930.69		+£0
Average monthly cash profit	-£10.45	(-7.1%)	+£0.03
(Sold stocks profit + Dividends - Fees / Months)

Just as things were looking a bit more promising, we drop a huge £51, so back to utter bleakness.

We'll soon have that trend line pointing downwards again!

I wonder how many time's I'll have to write that the portfolio has hit a new all-time low? I'm well and truly fed up.